✦ LIBER ✦

PND15 RELAPSING-REMITTING MULTIPLE SCLEROSIS (RR-MS) PATIENTS' VALUATION OF MS TREATMENT BENEFITS

✍ Scribed by J Narewska; A Lloyd; S Dewilde; SL Hass; DW Miller

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-8 and RANTES levels in patie

✍ H. Bartosik-Psujek; E. Belniak; K. Mitosek-Szewczyk; B. Dobosz; Z. Stelmasiak 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

The relationship between the internal ca

✍ Petek Balcı, B.; Günaydın, S.; Mutlu, A.; Çokar, A.Ö.; Acar, H.; Gürbüz, D. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Treatment of remitting-relapsing multipl

✍ Z. Stelmasiak; J. Nowicki; J. Solski; B. Jakubowska; M. Ryba; P. Grieb 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 86 KB

PND1 A Risk-Benefit Analysis of Natalizu

✍ A.R. Walker; B. Deniz; S.T. Alexopoulos; R. Arnold; D. Bates 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PND1 Estimating Net Health Benefits Of I

✍ S.M. Szabo; C. Dembek; P. Moore; L.A. White; H. Wijaya; A.R. Levy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PND3 Indirect Treatment Comparison (ITC)

✍ F.L. Allen; G. Osei-assibey; R. Arnold; B. Deniz 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB